Aclaris Therapeutics Names Jesse Hall Chief Medical Officer-March 2024-www.financetom.com

Aclaris Therapeutics Names Jesse Hall Chief Medical Officer

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Aclaris Therapeutics Names Jesse Hall Chief Medical Officer

May 25, 2025 9:02 PM

12:14 PM EDT, 04/29/2025 (MT Newswires) -- Aclaris Therapeutics ( ACRS ) said Tuesday that it has appointed Jesse Hall as chief medical officer, starting May 1.

Hall was most recently CMO at AltruBio, the biopharmaceutical company said.

Price: 1.36, Change: -0.01, Percent Change: -0.37

Previous page： National Bank Notes Aris Mining's Q4 Financials Below Street Estimates Next page： Update: Yext Fiscal Q4 Results Top Estimates; Fiscal 2025 Earnings Guidance Beats Forecast; Shares Shoot Higher Premarket

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

National Bank Notes Aris Mining's Q4 Financials Below Street Estimates

Mar 7, 2024

06:23 AM EST, 03/07/2024 (MT Newswires) -- National Bank noted that Aris Mining Corp. ( ARMN ) overnight Wednesday reported fourth-quarter 2023 operational and financial results and overall ascribed a neutral bias with financials below estimates. Adjusted EPS came in at $0.09, below National Bank's forecast of $0.11 and Street forecast of $0.14. Cash flow per share of $0.30 also...

Update: Yext Fiscal Q4 Results Top Estimates; Fiscal 2025 Earnings Guidance Beats Forecast; Shares Shoot Higher Premarket

Mar 7, 2024

06:20 AM EST, 03/07/2024 (MT Newswires) -- (Updates with the stock move in the headline and first paragraph.) Yext's ( YEXT ) shares soared more than 18% in premarket activity Thursday after the company's earnings in fiscal Q4 doubled from a year earlier, and its earnings guidance for the full financial year handily beat market expectations. The company reported fiscal...

GE Aerospace forecasts $10 billion operating profit in 2028, sets shareholder return target

Mar 7, 2024

NEW YORK (Reuters) -General Electric Co's ( GE ) aerospace business on Thursday reaffirmed its outlook for the current year and forecast a $10 billion of operating profit in 2028, citing robust demand for its products and services. The forecast comes ahead of GE's Aerospace's investor day later on Thursday. The aerospace business, which will become a standalone company on...

Genesis Land Development's Q4 Profit, Revenue Grows

Mar 7, 2024

06:17 AM EST, 03/07/2024 (MT Newswires) -- Genesis Land Development Corp. ( GNLAF ) overnight Wednesday reported fourth-quarter earnings of $8.1 million, or $0.15 per share, up from $3.1 million, or $0.05 per share, a year earlier. Revenue for the quarter ended Dec. 31, 2023, was $71.6 million, up from $54.2 million a year earlier. For land development, the total...